XML 57 R41.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Compensation Costs and Tax Benefit
Compensation cost charged against operations for the Plans and the 2017 MSPP described in "Note 10. Accumulated Other Comprehensive Income (Loss) and Shareholders’ Equity" was as follows:
 202420232022
Compensation cost$17.4 $16.5 $9.0 

The total income tax benefit recognized in the Consolidated Statements of Comprehensive Income for share-based compensation arrangements was as follows:
 202420232022
Income tax benefit$4.1 $4.2 $2.0 
The following table details deferred compensation and the affected line item in the Consolidated Balance Sheets where deferred compensation is presented:
December 28, 2024December 30, 2023
Current maturities of other long-term obligations$0.3 $0.3 
Other long-term liabilities3.0 2.1 
Total deferred compensation$3.3 $2.4 
Schedule of Changes in Restricted Stock Units
The following table summarizes the changes in RSUs (shares in thousands, per share amounts in dollars):
 Number of SharesWeighted-Average Grant Date Fair Value
Nonvested as of January 1, 2022545 $36.98 
Granted164 43.05 
Vested(141)36.99 
Forfeited(32)37.75 
Nonvested as of December 31, 2022535 $38.79 
Granted246 31.44 
Assumed228 *
Vested(259)34.71 
Forfeited(39)35.05 
Nonvested as of December 30, 2023713 $33.99 
Granted191 43.82 
Vested(419)35.32 
Forfeited(28)32.58 
Nonvested as of December 28, 2024456 $36.85 

*RSUs assumed in 2023 in the above table are replacement awards issued to Kimball International employees in June 2023, and have no weighted-average grant date fair value due to being granted prior to the Corporation’s acquisition of Kimball International. The total fair value of RSUs assumed at acquisition date is $6.1 million, with approximately 48 percent of the fair value attributed to service provided by Kimball International employees prior to the acquisition by the Corporation and thus is accounted for as purchase consideration. See "Note 4. Acquisitions and Divestitures" for further information.
The total value of shares vested was as follows:
202420232022
Value of shares vested$14.8 $9.0 $5.2 
Schedule of Changes in Performance Shares
The following table summarizes the changes in PSUs (shares in thousands, per share amounts in dollars):
 Number of SharesWeighted-Average Grant Date Fair Value
Nonvested as of January 1, 2022309 $37.29 
Granted143 43.67 
Forfeited(24)39.60 
Nonvested as of December 31, 2022428 $39.29 
Granted200 31.50 
Expired(142)37.60 
Forfeited(32)38.38 
Nonvested as of December 30, 2023455 $36.45 
Granted170 42.73 
Expired(49)36.99 
Vested(90)36.99 
Forfeited(17)38.46 
Nonvested as of December 28, 2024469 $38.50 
Schedule of Changes in Outstanding Stock Options
The following table summarizes the changes in outstanding stock options (shares in thousands, per share amounts in dollars):
 Number of SharesWeighted Average Exercise Price
Outstanding as of January 1, 20222,191 $41.62 
Exercised(64)33.35 
Forfeited or Expired(8)42.65 
Outstanding as of December 31, 20222,119 $41.86 
Exercised(225)36.06 
Forfeited or Expired(32)35.75 
Outstanding as of December 30, 20231,862 $42.67 
Exercised(1,115)44.31 
Outstanding as of December 28, 2024747 $40.22 
Schedule of Stock Option Vested or Expected to Vest and are Exercisable
Information about stock options currently exercisable is as follows (shares in thousands, per share amounts in dollars):
December 28, 2024
Number of SharesWeighted-Average Exercise PriceWeighted-Average Remaining Exercisable Period
(years)		Aggregate Intrinsic Value
Exercisable747 $40.22 3.5$8.0 
Schedule of Share-based Compensation Arrangement Other Information
Other information for the last three years is as follows:
202420232022
Total fair value of options vested$— $4.6 $4.7 
Total intrinsic value of options exercised$7.2 $0.8 $0.5 
Cash received from exercise of stock options$49.4 $8.1 $2.1 
Tax benefit realized from exercise of stock options$1.7 $0.2 $0.1